MPXI — MPX International Income Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0.064 | 1.59 | 3.17 | 7.21 |
Cost of Revenue | ||||
Gross Profit | 0.03 | 1.3 | 2.6 | 4.72 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 2.15 | 11.5 | 43.9 | 29.2 |
Operating Profit | -2.08 | -9.91 | -40.7 | -22 |
Total Net Non Operating Interest Income / Expense | ||||
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -2.11 | -9.12 | -41.7 | -26.4 |
Provision for Income Taxes | ||||
Net Income After Taxes | -2.11 | -9.38 | -41 | -26.6 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | -2.11 | -9.26 | -40.7 | -25.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -2.11 | -9.26 | -40.7 | -25.6 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.047 | -0.166 | -0.172 | -0.144 |